eMedicine Specialties > Infectious Diseases > CNS Infections

Meningitis: Differential Diagnoses & Workup

Author: Raymund R Razonable, MD, Consultant, Division of Infectious Diseases, Mayo Clinic of Rochester; Associate Professor of Medicine, Mayo Clinic College of Medicine
Coauthor(s): Michael R Keating, MD, Consultant, Assistant Professor of Medicine, Division of Infectious Diseases, Department of Medicine, Mayo Clinic College of Medicine
Contributor Information and Disclosures

Updated: Aug 26, 2009

Differential Diagnoses

Brain Abscess

Other Problems to Be Considered

Noninfectious meningitis, including medication-induced meningeal inflammation
Meningeal carcinomatosis
CNS vasculitis
Stroke
Encephalitis

Workup

Laboratory Studies

The cornerstone in the diagnosis of meningitis is examination of the CSF.

In general, whenever the diagnosis of meningitis is strongly considered, promptly perform a lumbar puncture.

Measure the opening pressure and send the fluid for cell count (and differential count), chemistry (ie, CSF glucose and protein), and microbiology (ie, Gram stain and cultures).

CT scan of the brain may be performed prior to lumbar puncture in some patient groups with a higher risk of herniation. These groups include those with newly onset seizures, an immunocompromised state, signs suspicious for space-occupying lesions (such as papilledema and focal neurologic signs), and moderate-to-severe impairment in consciousness.

Special studies, such as serology and nucleic acid amplification, may also be performed depending on clinical suspicion. There is increasing data to suggest that serum procalcitonin levels can be used as a guide to distinguish between bacterial and aseptic meningitis in children. The results yielded by a serum procalcitonin, combined with other findings, could be helpful in making clinical decisions.1

Table 5. CSF Picture of Meningitis According to Etiologic Agent

Open table in new window

Table
Agent
Opening Pressure
WBC count per µL
Glucose (mg/dL)
Protein (mg/dL)
Microbiology
Bacterial meningitis
200-300
100-5000; >80% PMNs*
<40
>100
Specific pathogen demonstrated in 60% of Gram stains and 80% of cultures
Viral meningitis
90-200
10-300; lymphocytes
Normal, reduced in LCM and mumps
Normal but may be slightly elevated
Viral isolation, PCR assays
Tuberculous meningitis
180-300
100-500; lymphocytes
Reduced, <40
Elevated, >100
Acid-fast bacillus stain, culture, PCR
Cryptococcal meningitis
180-300
10-200; lymphocytes
Reduced
50-200
India ink, cryptococcal antigen, culture
Aseptic meningitis
90-200
10-300; lymphocytes
Normal
Normal but may be slightly elevated
Negative findings on workup
Normal values
80-200
0-5; lymphocytes
50-75
15-40
Negative findings on workup
Agent
Opening Pressure
WBC count per µL
Glucose (mg/dL)
Protein (mg/dL)
Microbiology
Bacterial meningitis
200-300
100-5000; >80% PMNs*
<40
>100
Specific pathogen demonstrated in 60% of Gram stains and 80% of cultures
Viral meningitis
90-200
10-300; lymphocytes
Normal, reduced in LCM and mumps
Normal but may be slightly elevated
Viral isolation, PCR assays
Tuberculous meningitis
180-300
100-500; lymphocytes
Reduced, <40
Elevated, >100
Acid-fast bacillus stain, culture, PCR
Cryptococcal meningitis
180-300
10-200; lymphocytes
Reduced
50-200
India ink, cryptococcal antigen, culture
Aseptic meningitis
90-200
10-300; lymphocytes
Normal
Normal but may be slightly elevated
Negative findings on workup
Normal values
80-200
0-5; lymphocytes
50-75
15-40
Negative findings on workup

*Polymorphonuclear lymphocytes
†Polymerase chain reaction

Bacterial meningitis

  • Examination of the CSF in patients with acute bacterial meningitis reveals the characteristic neutrophilic pleocytosis (usually hundreds to a few thousand, with >80% PMN cells). In some cases of L monocytogenes meningitis (25-30%), a lymphocytic predominance may occur. Low CSF WBC count (<20 cells/µL) in the presence of a high bacterial load suggests a poor prognosis.
  • The opening pressure (reference range is 80-200 mm H2O) may be elevated, suggesting some form of increased ICP from cerebral edema.
  • The CSF glucose (reference range is 40-70 mg/dL) is less than 40 mg/dL in 60% of patients. Obtain a simultaneous blood glucose determination for comparison purposes. Some patients may have elevated blood sugar levels as a result of underlying diabetes mellitus, and the predictive value of the CSF and blood sugar ratio may not be accurate in these circumstances.
  • The CSF protein (reference range is 20-50 mg/dL) is usually elevated.
  • CSF Gram stain permits rapid identification of the bacterial cause in 60-90% of patients with bacterial meningitis. The presence of bacteria is 100% specific, but the sensitivity for detection is variable. The likelihood of detection is higher in the presence of a higher bacterial concentration and diminishes with prior antibiotic use.
  • CSF bacterial cultures yield the bacterial cause in 70-85% of cases. The yield diminishes significantly in patients who have received antimicrobial therapy. In these cases, some experts advocate the use of a CSF bacterial antigen assay. This is a latex agglutination technique that can detect the antigens of HIB, S pneumoniae, N meningitidis, E coli K1, and S agalactiae. Its theoretical advantage is the detection of the bacterial antigens even after microbial killing, as is observed following antibacterial therapy. Others, however, have shown that it may not be better than the Gram stain. It is specific (a positive result indicates a diagnosis of bacterial meningitis), but a negative finding on bacterial antigen test does not rule out meningitis (50-95% sensitivity).
  • Obtain blood cultures and appropriate cultures from possible sites of infection. Obtain these promptly and prior to the administration of an antibacterial agent. The utility of these cultures is most evident in cases when the performance of a lumbar puncture is delayed by the need for head imaging (risk for herniation in a patient with focal neurologic deficit or coma) and when antimicrobial therapy is rightfully initiated before the lumbar puncture and neuroimaging tests.

Acute viral meningitis

  • The CSF picture of acute viral meningitis is different from the CSF picture of bacterial meningitis.
  • The opening pressure is usually within the reference range.
  • The CSF cell count is usually in the few hundreds (100-1000 cells/µL) with a predominance of lymphocytes. Some cases of echovirus, mumps, and HSV meningitis may produce a neutrophilic picture early in the course of disease.
  • The CSF glucose level is usually within the reference range, but some cases of LCM, HSV, mumps, and polio may cause low CSF glucose levels.
  • CSF protein levels may be within the reference range but are usually elevated.
  • Virus isolation from the CSF can be performed. It has a sensitivity of 65-70% for enteroviruses. Alternatively, enterovirus isolation from throat and stool viral cultures may also be used to indirectly implicate it as the cause of the meningitis. Mumps viral culture from the CSF has a low sensitivity (30-50%). LCM virus may be cultured in blood early in the disease or later in the urine.
  • The use of nucleic acid amplification (eg, PCR) has revolutionized the diagnosis of herpes simplex meningitis. The availability of this technique has confirmed HSV as the cause of the recurrent Mollaret meningitis. This technique has also been applied to the diagnosis of enterovirus infections and the other herpesvirus infections. The PCR assay for enteroviruses has been demonstrated to be substantially more sensitive than culture and is 94-100% specific.
  • In addition, the demonstration of a 4-fold rise between acute and convalescent sera traditionally has been used to document meningeal infection with these viral pathogens.

Cryptococcal meningitis

  • The diagnosis of cryptococcal meningitis relies on the identification of the pathogen in the CSF.
  • The CSF is characterized by a lymphocytic pleocytosis (10-200 lymphocytes), a reduced glucose level, and an elevated protein level.
  • The CSF opening pressure may be elevated at times, suggesting increased ICP.
  • C neoformans may be cultured from the CSF. Other methods of identification have included India ink preparation and the detection of CSF cryptococcal antigen. India ink has a sensitivity of only 50%, but it is highly diagnostic if positive. Because of the low sensitivity of the India ink preparation, many centers have adapted the use of CSF cryptococcal antigen determination, a test with a sensitivity of greater than 90%. However, the CSF cryptococcal antigen determination is not universally available. In instances when the India ink results are negative but the clinical suspicion for cryptococcal meningitis is high, the CSF specimen may be sent to reference laboratories that can perform CSF cryptococcal antigen determination to confirm the diagnosis. In addition, the titer of the antigen could serve to monitor the response to treatment.
  • Obtain blood cultures and serum cryptococcal antigen to determine if cryptococcal fungemia is present.

Other fungal meningitis

  • The CSF picture of other fungal meningitis is similar to the CSF picture of cryptococcal meningitis, usually with lymphocytic pleocytosis.
  • Eosinophilic pleocytosis has rarely been associated with C immitis meningitis.
  • The definitive diagnosis usually relies on the demonstration of the specific fungal agent (eg, H capsulatum, C immitis, B dermatitidis, Candida species) from clinical specimens, including the CSF. This could be in the form of fungal culture isolation (eg, C albicans growth from CSF). More commonly, fungal serology is used in the diagnosis of many cases of fungal meningitis because isolating them from culture has been difficult (eg, presence of histoplasma antigen in the CSF). However, note that the serology for B dermatitidis is not accurate and a negative serology finding does not rule out the diagnosis.

Syphilitic meningitis

  • The CSF in syphilitic meningitis is characterized by mild lymphocytic pleocytosis.
  • Abnormal CSF protein levels (elevated) and CSF glucose levels (decreased) may be observed in 10-70% of cases.
  • Isolating T pallidum from the CSF is extremely difficult and time consuming. The spirochete could be demonstrated using dark-field or phase-contrast microscopy on specimens collected from skin lesions (eg, chancres and other syphilitic lesions).
  • The diagnosis is usually supported by the CSF Venereal Disease Research Laboratory (VDRL) test, which has a sensitivity of 30-70% (a negative result on the CSF VDRL test does not rule out syphilitic meningitis) and a high specificity (a positive test result suggests the disease). Always take care to not contaminate the CSF with blood during spinal fluid collection (eg, traumatic tap).
  • Perform serologic tests to detect syphilis, such as the nontreponemal (ie, rapid plasma reagent [RPR] or VDRL test) and specific treponemal (ie, fluorescent treponemal antibody absorption [FTA-Abs], Treponema pallidum hemoagglutination [TPHA], microhemagglutination-Treponema pallidum [MHA-TP]) tests to support the diagnosis. These also guide the success of therapy. The titer of the nonspecific treponemal tests decreases and usually reverts back to negative or undetectable levels following treatment.

Lyme neuroborreliosis

  • The CSF in patients with Lyme meningitis is characterized by low-grade lymphocytic pleocytosis, low glucose levels, and elevated protein levels. Oligoclonal bands reactive to B burgdorferi antigens may be present.
  • Demonstration of the specific antibody to B burgdorferi aids in the diagnosis. Comparison between the antibody response in the CSF and the serum is a helpful diagnostic test. A CSF-to-serum ratio of greater than 1 suggests intrathecal antibody production and neuroborreliosis.
  • The culture for B burgdorferi has a low yield.
  • The recent availability of the CSF Lyme PCR assay offers a rapid, sensitive, and specific method of diagnosis. This assay is gaining popularity as the method of choice for diagnosis of Lyme meningitis. Findings on blood Lyme PCR are usually negative.

Tuberculosis meningitis

  • The CSF of patients with tuberculosis meningitis is characterized by a predominantly lymphocytic pleocytosis, usually in the hundreds.
  • The opening CSF pressure is usually elevated.
  • A characteristic hypoglycorrhagia (glucose <40 mg/dL) is present, and the protein level is usually elevated, especially if a CSF block is present.
  • The demonstration of the acid-fast bacilli (eg, with auramine-rhodamine stain, Ziehl-Neelsen stain, Kinyoun stain) in the CSF is difficult and usually requires a large volume of CSF.
  • Meningeal biopsy, with the demonstration of caseating granulomas and acid-fast bacilli on the smear, may prove useful because it has a higher yield than the CSF acid-fast bacilli smear.
  • The culture for Mycobacterium usually takes several weeks and may delay definitive diagnosis.
  • M tuberculosis detection assays involving nucleic acid amplification have become available and have the advantage of a rapid, sensitive, and specific method of tuberculosis detection.
  • The need for mycobacterial growth in cultures remains because this offers the advantage of performing drug susceptibility assays.

Parasitic meningitis

  • PAM caused by N fowleri is characterized by a neutrophilic pleocytosis, low glucose levels, elevated protein levels, and red blood cells. Mononuclear pleocytosis may be observed in patients with subacute or chronic forms of PAM. Demonstration of the trophozoites, with the characteristic amoeboid movement, using wet preparations of the CSF has been used for diagnosis. Alternatively, the amoeba could be demonstrated in biopsy specimens.
  • Suspect meningitis caused by A cantonensis, G spinigerum, and B procyonis in the presence of exposure, profound peripheral blood eosinophilia, and characteristic eosinophilic pleocytosis. Demonstrating the larva antemortem is usually difficult, and diagnosis relies on clinical presentation and a compatible epidemiological history. Serologic tests may aid in the diagnosis. G spinigerum meningitis may mimic cerebrovascular disease because it may cause cerebral hemorrhage.

Imaging Studies

  • Computed tomography scans of the head and magnetic resonance imaging of the brain do not aid in the diagnosis of meningitis. Some patients may show meningeal enhancement, but its absence does not rule out the condition.
  • The practice of obtaining CT scans of the head may lead to the unnecessary delay in the performance of diagnostic lumbar puncture and the initiation of antibiotic therapy. The delay in the institution of antimicrobial therapy may be detrimental to the total outcome in these patients. Cerebral herniation following the lumbar tap procedure is rare in individuals with no focal neurologic deficits and no evidence of increased ICP. If it occurs, it usually happens within 24 hours following the lumbar puncture and should always be considered in the differential diagnosis if the patient's neurologic status deteriorates.
  • Neuroimaging is indicated in patients with prolonged fever, focal neurologic symptoms and signs, evidence of increased ICP, and suspected basilar fracture. It is also indicated for evaluation of the paranasal sinuses. These studies are helpful in the detection of CNS complications of bacterial meningitis, such as hydrocephalus, cerebral infarct, brain abscess, subdural empyema, and venous sinus thrombosis.

Procedures

  • Perform lumbar puncture promptly in all patients whenever a strong clinical suspicion for meningitis exists.
  • Neurosurgical procedures are performed in consultation with a neurosurgical service in the presence of severe intracranial hypertension, evidence of paranasal and mastoid infection that requires surgical drainage, skull fractures, foreign body–associated infections (eg, ventriculoperitoneal shunts), or an associated abscess formation.

More on Meningitis

Overview: Meningitis
Differential Diagnoses & Workup: Meningitis
Treatment & Medication: Meningitis
Follow-up: Meningitis
Multimedia: Meningitis
References
Further Reading

References

  1. [Best Evidence] Dubos F, Korczowski B, Aygun DA, Martinot A, Prat C, Galetto-Lacour A, et al. Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicenter case cohort study. Arch Pediatr Adolesc Med. Dec 2008;162(12):1157-63. [Medline].

  2. van de Beek D, de Gans J. Dexamethasone and pneumococcal meningitis. Ann Intern Med. Aug 17 2004;141(4):327. [Medline][Full Text].

  3. [Best Evidence] Sloan D, Dlamini S, Paul N, Dedicoat M. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings. Cochrane Database Syst Rev. Oct 8 2008;CD005647. [Medline].

  4. Archer BD. Computed tomography before lumbar puncture in acute meningitis: a review of the risks and benefits. CMAJ. Mar 15 1993;148(6):961-5. [Medline].

  5. Assiri AM, Alasmari FA, Zimmerman VA, Baddour LM, Erwin PJ, Tleyjeh IM. Corticosteroid administration and outcome of adolescents and adults with acute bacterial meningitis: a meta-analysis. Mayo Clin Proc. May 2009;84(5):403-9. [Medline].

  6. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. Mar 2000;19(3):187-95. [Medline].

  7. Centers for Disease Control and Prevention. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. Jun 30 2000;49(RR-7):1-10. [Medline].

  8. Centers for Disease Control and Prevention. Summary of Notifiable Diseases, United States, 1998. MMWR Morb Mortal Wkly Rep. Dec 31 1999;47(53):ii-92. [Medline].

  9. Chamberlain MC, Glantz M. Myelomatous meningitis. Cancer. Apr 1 2008;112(7):1562-7. [Medline].

  10. Connolly KJ, Hammer SM. The acute aseptic meningitis syndrome. Infect Dis Clin North Am. Dec 1990;4(4):599-622. [Medline].

  11. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med. Nov 14 2002;347(20):1549-56. [Medline][Full Text].

  12. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. Jan 7 1993;328(1):21-8. [Medline].

  13. Elmore JG, Horwitz RI, Quagliarello VJ. Acute meningitis with a negative Gram's stain: clinical and management outcomes in 171 episodes. Am J Med. Jan 1996;100(1):78-84. [Medline].

  14. Fitch MT, van de Beek D. Emergency diagnosis and treatment of adult meningitis. Lancet Infect Dis. Mar 2007;7(3):191-200. [Medline].

  15. Fong IW, Tomkins KB. Review of Pseudomonas aeruginosa meningitis with special emphasis on treatment with ceftazidime. Rev Infect Dis. Sep-Oct 1985;7(5):604-12. [Medline].

  16. Friedland IR, McCracken GH Jr. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med. Aug 11 1994;331(6):377-82. [Medline].

  17. Girgis NI, Farid Z, Mikhail IA, et al. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J. Dec 1989;8(12):848-51. [Medline].

  18. Gold R. Epidemiology of bacterial meningitis. Infect Dis Clin North Am. Sep 1999;13(3):515-25, v. [Medline].

  19. Gopal AK, Whitehouse JD, Simel DL, Corey GR. Cranial computed tomography before lumbar puncture: a prospective clinical evaluation. Arch Intern Med. Dec 13-27 1999;159(22):2681-5. [Medline].

  20. Hasbun R, Abrahams J, Jekel J, Quagliarello VJ. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med. Dec 13 2001;345(24):1727-33. [Medline][Full Text].

  21. Hasbun R, Aronin SI, Quagliarello VJ. Treatment of bacterial meningitis. Compr Ther. Feb 1999;25(2):73-81. [Medline].

  22. Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med. Aug 24 1995;333(8):481-6. [Medline].

  23. [Guideline] Kauffman CA, Hajjeh R, Chapman SW. Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America. Clin Infect Dis. Apr 2000;30(4):684-7. [Medline].

  24. Leib SL, Tauber MG. Pathogenesis of bacterial meningitis. Infect Dis Clin North Am. Sep 1999;13(3):527-48, v-vi. [Medline].

  25. Leonard JM, Des Prez RM. Tuberculous meningitis. Infect Dis Clin North Am. Dec 1990;4(4):769-87. [Medline].

  26. Logan SA, MacMahon E. Viral meningitis. BMJ. Jan 5 2008;336(7634):36-40. [Medline].

  27. McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA. Sep 17 1997;278(11):925-31. [Medline].

  28. Mongelluzzo J, Mohamad Z, Ten Have TR, Shah SS. Corticosteroids and mortality in children with bacterial meningitis. JAMA. May 7 2008;299(17):2048-55. [Medline].

  29. Mylonakis E, Hohmann EL, Calderwood SB. Central nervous system infection with Listeria monocytogenes. 33 years' experience at a general hospital and review of 776 episodes from the literature. Medicine (Baltimore). Sep 1998;77(5):313-36. [Medline].

  30. Nigrovic LE, Malley R, Macias CG, Kanegaye JT, Moro-Sutherland DM, Schremmer RD, et al. Effect of antibiotic pretreatment on cerebrospinal fluid profiles of children with bacterial meningitis. Pediatrics. Oct 2008;122(4):726-30. [Medline].

  31. Prasad K, Volmink J, Menon GR. Steroids for treating tuberculous meningitis (Cochrane review). Cochrane Database Syst Rev. 2000;(3):CD002244. [Medline].

  32. Quagliarello VJ, Scheld WM. Treatment of bacterial meningitis. N Engl J Med. Mar 6 1997;336(10):708-16. [Medline].

  33. [Guideline] Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis. Apr 2000;30(4):710-8. [Medline].

  34. Sandkovsky U, Mihu MR, Adeyeye A, De Forest PM, Nosanchuk JD. Iatrogenic meningitis in an obstetric patient after combined spinal-epidural analgesia: case report and review of the literature. South Med J. Mar 2009;102(3):287-90. [Medline].

  35. Sawyer MH. Enterovirus infections: diagnosis and treatment. Pediatr Infect Dis J. Dec 1999;18(12):1033-9; quiz 1040. [Medline].

  36. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics. Feb 1997;99(2):226-31. [Medline].

  37. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med. Oct 2 1997;337(14):970-6. [Medline].

  38. Talan DA, Zibulewsky J. Relationship of clinical presentation to time to antibiotics for the emergency department management of suspected bacterial meningitis. Ann Emerg Med. Nov 1993;22(11):1733-8. [Medline].

  39. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. Oct 21 2004;351(17):1741-51. [Medline][Full Text].

  40. van de Beek D, de Gans J, McIntyre P, Prasad K. Corticosteroids in acute bacterial meningitis. Cochrane Database Syst Rev. 2003;CD004305. [Medline].

  41. van de Beek D, de Gans J, McIntyre P, Prasad K. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis. Mar 2004;4(3):139-43. [Medline][Full Text].

  42. van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. Oct 28 2004;351(18):1849-59. [Medline][Full Text].

Keywords

bacterial meningitis, aseptic meningitis, viral meningitis, tuberculous meningitis, syphilitic meningitis, Lyme meningitis, cryptococcal meningitis, fungal meningitis, parasitic meningitis, inflammation of the meninges, headache, nuchal rigidity, photophobia, pleocytosis, acute meningitis, chronic meningitis, Streptococcus pneumoniae meningitis, meningococcal meningitis, Haemophilus influenzae meningitis, Histoplasma meningitis, amebic meningoencephalitis

Contributor Information and Disclosures

Author

Raymund R Razonable, MD, Consultant, Division of Infectious Diseases, Mayo Clinic of Rochester; Associate Professor of Medicine, Mayo Clinic College of Medicine
Raymund R Razonable, MD is a member of the following medical societies: American Medical Association, American Society for Microbiology, Infectious Diseases Society of America, and International Immunocompromised Host Society
Disclosure: Nothing to disclose.

Coauthor(s)

Michael R Keating, MD, Consultant, Assistant Professor of Medicine, Division of Infectious Diseases, Department of Medicine, Mayo Clinic College of Medicine
Michael R Keating, MD is a member of the following medical societies: American College of Physicians, American Medical Association, American Society for Microbiology, American Society of Transplantation, Infectious Diseases Society of America, and International Immunocompromised Host Society
Disclosure: Nothing to disclose.

Medical Editor

Joseph Richard Masci, MD, Chief of Infectious Diseases, Associate Director, Associate Professor, Department of Internal Medicine, Division of Infectious Diseases, Elmhurst Hospital Center, Mount Sinai School of Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

John W King, MD, Professor of Medicine, Chief, Section of Infectious Diseases, Director, Viral Therapeutics Clinics for Hepatitis, Louisiana State University Health Sciences Center; Consultant in Infectious Diseases, Overton Brooks Veterans Affairs Medical Center
John W King, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Federation for Medical Research, American Society for Microbiology, Association of Subspecialty Professors, Infectious Diseases Society of America, and Sigma Xi
Disclosure: emedicine $50.00 author of chapter

CME Editor

Eleftherios Mylonakis, MD, Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital
Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD, Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital
Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.